The finalists for the 2024 Quality in Care (QiC) Diabetes Awards have been revealed.
QiC Diabetes recognises, rewards and shares innovative practice demonstrating quality in diabetes management, education and services for people with the condition and/or their families.
The use of a tubeless automated insulin delivery (AID) system led to improved glycaemic outcomes among adults with type 1 diabetes, a new study has shown.
Greater glycaemic improvements were seen among people using the tubeless Omnipod® 5 AID system compared to those with type 1 diabetes on pump therapy with a continuous glucose monitor (CGM).
A set of new practical recourses to help address some common gaps in diabetes care have been released.
Insights for Diabetes Excellence, Access and Learning (iDEAL) Diabetes has developed the resources to provide high quality educational material to healthcare professionals on key areas that can often be overlooked.
Hundreds of healthcare sites across the UK and Ireland took part in Hypo Awareness Week.
The annual campaign gives healthcare professionals and the diabetes community the opportunity to discuss hypoglycaemia in hospitals and primary care settings. This year, it took place between October 7 and 13.
A woman living with type 1 diabetes has been cured after being injected with programmed stem cells.
Researchers from institutions across China took cells from the woman and reverted them to a pluripotent state.
Canagliflozin was linked to a 2.1 per cent increase in total iron-binding capacity and improved haemoglobin levels for people with CKD and type 2 diabetes. To read more, click here.
GLP-1 receptor agonists (GLP-1s) were more effective than metformin in reducing HbA1c levels among people with type 2 diabetes, research shows. To read more, click here.
Diabetes and multiple long-term conditions will be the focus of a free healthcare professional primary care conference next month. To read more, click here.
A senior DSN is calling for support as she aims to deliver crucial diabetes supplies to a number of African nations, including Ghana and Kenya. To read more, click here.
The Medicines and Healthcare products Regulatory Agency (MHRA) is asking people who use a continuous glucose monitor (CGM) or insulin pump to report any safety problem with their device through the MHRA Yellow Card scheme without delay.
More than 5.6 million people in the UK live with diabetes, many of whom rely on these devices to manage their condition, and their use can significantly improve the quality of life for those with the condition.
Children who have contracted COVID-19 are more at risk of developing type 2 diabetes in the future compared to those never infected with the disease. To read more, click here.
Scientists from the University of Leicester have discovered that tuberculosis disrupts glucose metabolism in the body. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Senior Clinical Fellow in Diabetes & Endocrinology – Royal Free London NHS Foundation Trust
Specialist Midwife for Diabetes – Medway NHS Foundation Trust
Consultant in Endocrinology, Diabetes & General Internal Medicine – University Hospitals Sussex NHS Foundation Trust
Consultant in Diabetes & Endocrinology – County Durham & Darlington NHS Foundation Trust
